Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.95 - $27.04 $7,915 - $12,627
467 Added 3.72%
13,029 $352,000
Q1 2024

May 15, 2024

SELL
$11.38 - $19.03 $32,979 - $55,148
-2,898 Reduced 18.75%
12,562 $230,000
Q3 2023

Nov 14, 2023

SELL
$14.99 - $32.65 $891,665 - $1.94 Million
-59,484 Reduced 79.37%
15,460 $231,000
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $1.41 Million - $2.18 Million
47,276 Added 170.87%
74,944 $2.43 Million
Q4 2022

Feb 14, 2023

SELL
$40.54 - $56.2 $87,485 - $121,279
-2,158 Reduced 7.24%
27,668 $1.46 Million
Q3 2022

Mar 03, 2023

BUY
$36.98 - $49.2 $79,802 - $106,173
2,158 Added 7.8%
29,826 $1.34 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $514,058 - $683,929
13,901 Added 87.29%
29,826 $1.34 Million
Q2 2022

Aug 15, 2022

BUY
$28.03 - $45.8 $58,694 - $95,905
2,094 Added 15.14%
15,925 $580,000
Q1 2022

May 16, 2022

SELL
$29.24 - $44.06 $84,854 - $127,862
-2,902 Reduced 17.34%
13,831 $571,000
Q4 2021

Feb 14, 2022

BUY
$39.32 - $61.61 $140,804 - $220,625
3,581 Added 27.23%
16,733 $713,000
Q2 2021

Aug 16, 2021

BUY
$44.66 - $63.06 $55,824 - $78,825
1,250 Added 10.5%
13,152 $629,000
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $12,874 - $17,430
278 Added 2.39%
11,902 $603,000
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $121,955 - $153,658
2,197 Added 23.31%
11,624 $732,000
Q3 2020

Nov 16, 2020

SELL
$42.19 - $69.61 $65,774 - $108,521
-1,559 Reduced 14.19%
9,427 $634,000
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $88,518 - $139,058
3,213 Added 41.34%
10,986 $460,000
Q1 2020

May 15, 2020

BUY
$23.16 - $47.8 $11,742 - $24,234
507 Added 6.98%
7,773 $245,000
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $203,230 - $293,401
7,266 New
7,266 $293,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.